CClinicalTrials.gg
CompletedNCT00954772MOSTUpdated Dec 2, 2011

Mood and Subthalamic Nucleus (STN) Deep Brain Stimulation

An observational study in Movement Disorders, sponsored by University of Florida. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2011-12-02.

Sponsored by University of Florida · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
91
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The purpose of this research study is to investigate any changes seen in mood or behavior following deep brain stimulation for movement disorders.

02

Conditions studied

  • Movement Disorders

Browse trials for

Keywords

  • Staged versus Simultaneous Bilateral DBS
03

In context

Movement Disorders

320 studies on the registry are indexed under Movement Disorders; 98 are open to participants now.

This study's enrollment of 91 is above the median of 80 across 132 observational studies indexed under Movement Disorders.

Browse Movement Disorders studies →

Lead sponsor

University of Florida is the lead sponsor of 1,254 studies on the registry; 201 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 136 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Parkinson's patients who undergo STN DBS

Inclusion criteria

  • Idiopathic PD diagnosed by a movement disorders neurologist
  • Approved by a movement disorders neurologist as clinically needing a DBS device
  • Absence of significant cognitive dysfunction (Mattis Dementia Rating Scale Score of greater than or equal to 116)
  • MRI without evidence of structural abnormality (stroke, tumor, malformation, etc)
  • No prior neurosurgical intervention

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
91 participants (actual)

Groups and cohorts

  • Staged Bilateral STN DBS
  • Simultaneous Bilateral STN DBS
06

Study locations

1 site
  • Mt. Sinai School of Medicine
    New York, New York 10029, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00954772
Lead sponsor
University of Florida
Collaborators
National Parkinson Foundation
Responsible party
Sponsor
First posted
Aug 7, 2009
Start date
Jul 2005
Primary completion
Jun 2011
Completion
Jun 2011
Last update
Dec 2, 2011

Study contacts

Michael S Okun, MD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion